Kemocarb

Kemocarb

carboplatin

Manufacturer:

Fresenius Kabi

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Carboplatin
Indications/Uses
Treatment of advanced ovarian cancer. In combination w/ other chemotherapeutic agents for treatment of small-cell lung cancer, non-small cell lung cancer, head & neck cancer & in genitourinary cancer, particularly in testicular, bladder & cervical cancers.
Dosage/Direction for Use
400 mg/m2 by IV infusion over 15 min-1 hr every 4 wk.
Contraindications
History of severe allergic reactions to cisplatin or other platinum-containing compd. Severe bone marrow depression, significant bleeding. Pregnancy, lactation.
Special Precautions
Blood counts, neurological & renal functions to be monitored closely.
Adverse Reactions
Bone marrow suppression, thrombocytopenia, neutropenia, anaemia, vomiting, nausea, neurologic toxicity, nephrotoxicity.
ATC Classification
L01XA02 - carboplatin ; Belongs to the class of platinum-containing antineoplastic agents. Used in the treatment of cancer.
Presentation/Packing
Form
Kemocarb infusion 450 mg/45 mL
Packing/Price
1's
Form
Kemocarb infusion 150 mg/15 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in